Eotaxin-1-deficient mice develop airway eosinophilia and airway hyperresponsiveness

International Archives of Allergy and Immunology

Volumn 126, Issue 2, 2001, Pages 119-125

  Tomkinson, A ^a   Duez, C ^a   Cieslewicz, G ^a   Gelfand, E W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Airway eosinophilia; Airway hyperresponsiveness; Eotaxin

Indexed keywords

ALLERGEN; BASIC PROTEIN; CHEMOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; METHACHOLINE; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE COURSE; EOSINOPHIL; EOSINOPHILIA; FEMALE; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ALLERGENS; ANIMALS; BLOOD CELL COUNT; BONE MARROW; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CC; FEMALE; LEUKOCYTE COUNT; MALE; METHACHOLINE CHLORIDE; MICE; OVALBUMIN; PULMONARY EOSINOPHILIA;

EID: 0035208590     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049502     Document Type: Article

References (39)

1. Eosinophilic inflammation in asthma
2. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions
3. The eosinophil and bronchial asthma: Current understanding
4. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
5. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
6. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
7. Chemokines and chemokine receptors: Their role in allergic airway disease
8. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
9. Recombinant human interleukin 5 is a selective activator of human eosinophil function
10. Mechanisms of eosinophil recruitment
11. Role of the monocyte chemoattractant protein and eotaxin sub-family of chemokines in allergic inflammation
12. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues
13. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils
14. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3
15. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes
16. Cloning and functional expression of a human eosinophil CC chemokine receptor
17. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
18. Polymorphisms in the human CC chemokine receptor-3 gene
19. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils
20. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation
21. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung
22. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response
23. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
24. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3
25. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
26. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells
27. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis
28. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhallation
29. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
30. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity
31. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia
32. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils
33. Eotaxin is a potent chemotaxin for human basophils
34. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
35. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4
36. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
37. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
38. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin
39. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice